Search results for " ALZHEIMER"

showing 10 items of 149 documents

The Contribution of Microscopy to the Study of Alzheimer’s Disease, Amyloid Plaques and Aβ Fibrillogenesis

2006

A broad survey is presented in this chapter, dealing with the impact that microscopy has made to the study of Alzheimer’s disease, amyloid plaques and amyloid-β fibrillogenesis. This includes classical light microscopy and the modern immunolabelling and confocal microscopies, together with the contribution of transmission electron microscopy and atomic force microscopy. Whilst usefully standing alone, the individual microscopies often contribute most effectively when they are integrated with cellular, biophysical and molecular approaches.

ChemistrylawConfocalMicroscopyP3 peptideBiophysicsFibrillogenesisSenile plaquesElectron microscopeFibrilBiochemistry of Alzheimer's diseaselaw.invention
researchProduct

What's Curcumin's mind? The potential role of Curcuminoids in the treatment of Alzheimer's disease

2020

Neurodegenerative diseases (NDs) are one of major public health problems and their impact is continuously growing. Curcumin has been proposed for the treatment of several of these pathologies, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) due to the ability of this molecule to reduce inflammation and aggregation of involved proteins. Nevertheless, the poor metabolic stability and bioavailability of curcumin reduce the possibilities of its practical use. In this review will be highlighted recent results on curcumin and curcuminoids in the search of new effective therapeutic agents against NDs, with particular emphasis on AD.

Curcumin Alzheimer’s Disease amiloyd peptideSettore CHIM/06 - Chimica Organica
researchProduct

Biomarkers clinici, biologici, cognitivi e comportamentali per la malattia di Alzheimer ed il Mild Cognitive Impairment: dati di popolazione dello Za…

Nel 2015, quasi 47 milioni di persone in tutto il mondo sono state colpite da demenza, e si prevede che i valori raggiungeranno 75 milioni entro il 2030 e 131 milioni entro il 2050, con il maggiore aumento previsto nei paesi a basso e medio reddito. Nonostante gli enormi costi dell'assistenza medica e sociale per i pazienti affetti da AD dipendano dalla gravità della malattia, i dati sulla prevalenza della demenza sulla base della gravità o dello stadio sono carenti soprattutto nei contesti rurali e con basso livello di istruzione. L'obiettivo principale di questo studio è di valutare l'interazione tra fattori di rischio legati alla fragilità, le performance cognitive e i sintomi comportame…

Demenza Sindrome di Alzheimer Mild Cognitive Impairment Subjective Cognitive Decline prevalenza fattori associati
researchProduct

Galantamine delivery on buccal mucosa: permeation enhancement and design of matrix tablets

2009

The most important feature in transbuccal drug delivery is the low drug passage through the buccal mucosa. In our previous work we demonstrated the aptitude of Galantamine to penetrate the buccal tissue. The collected data suggested that Galantamine passively crosses the membrane, but the calculated Js and Kp values showed that the drug amount that crosses the membrane wasn’t sufficient to assure blood therapeutic level. So, in this study, ex vivo permeation tests, using porcine buccal mucosa, were performed in presence of physical or chemical enhancers. No significant differences in penetration rate were observed using chemical enhancers as sodium dehydrocholate, EDTA disodium salt and tri…

Drugbusiness.industrymedia_common.quotation_subjectPharmaceutical ScienceBuccal administrationPharmacologyPermeationBuccal mucosaDosage formstomatognathic systemSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryGalantamineMedicineTransbuccal delivery Galantamine Permeation enhancement Alzheimer’s diseasebusinessEx vivomedicine.drugmedia_common
researchProduct

New Prospectives in the Delivery of Galantamine for Elderly Patients Using the IntelliDrug Intraoral Device: In Vivo Animal Studies

2009

The transbuccal delivery of drugs could assist several categories of chronic, especially elderly, patients in adhering to a correct dosage regimen. In particular, patients suffering from dementia have several difficulties in following the prescribed dosage, in addition to problems associated with swallowing tablets. Galantamine is currently used for treating patients with mild to moderate Alzheimer's-type dementia. The transbuccal delivery of this drug could be an interesting non- invasive and safe administration route. Several studies have been performed in vitro and ex vivo within the framework of a European Commission funded Project (IntelliDrug-FP6), aimed at developing a device which w…

Drugmedicine.medical_specialtySwinemedia_common.quotation_subjectSettore MED/50 - Scienze Tecniche Mediche ApplicateAdministration OralPilot ProjectsRoute of administrationDrug Delivery SystemsIn vivoOral administrationDrug DiscoveryGalantaminemedicineAnimalsHumansAgedmedia_commonPharmacologyGalantaminebusiness.industryMouth MucosaTransbuccal drug delivery Alzheimer disease GalantamineAdministration BuccalBuccal administrationSurgeryRegimenSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryFemalebusinessmedicine.drugCurrent Pharmaceutical Design
researchProduct

EGFR signalling is required for Paracentrotus lividus endomesoderm specification

2008

The EGFR pathway is critical for cell fate specification throughout the development of several organisms. Here we identified in sea urchin an EGFR-related antigen maternally expressed and showing a dynamic pattern of localization during development. To investigate the role played by the EGFR in Paracentrotus lividus development we blocked its activity by using the EGFR kinase inhibitor AG1478. This treatment produces decrease of EGFR phosphorylation, and embryos with various defects especially in the endomesoderm territory until to obtain an animalized phenotype. These effects are rescued by the addition of TGF-alpha, an EGFR ligand. The role played by EGFR-like along the animal/vegetal axi…

Embryo NonmammalianMAP Kinase Signaling SystemBlotting WesternBiophysicsCell fate determinationBiochemistryParacentrotus lividusMesodermEndomesodermbiology.animalBotanyAnimalsCell LineageExtracellular Signal-Regulated MAP KinasesMolecular BiologySea urchinbiologyKinaseEndodermEmbryoTyrphostinsbiology.organism_classificationImmunohistochemistryPhenotypeCell biologyErbB ReceptorsParacentrotusQuinazolinesPhosphorylationEGFR sea urchin AlzheimerSignal TransductionArchives of Biochemistry and Biophysics
researchProduct

Expression of the Anti-amyloidogenic Secretase ADAM10 Is Suppressed by Its 5′-Untranslated Region*

2010

Proteolytic processing of the amyloid precursor protein by alpha-secretase prevents formation of the amyloid beta-peptide (Abeta), which is the main constituent of amyloid plaques in brains of Alzheimer disease (AD) patients. alpha-Secretase activity is decreased in AD, and overexpression of the alpha-secretase ADAM10 (a disintegrin and metalloprotease 10) in an AD animal model prevents amyloid pathology. ADAM10 has a 444-nucleotide-long, very GC-rich 5'-untranslated region (5'-UTR) with two upstream open reading frames. Because similar properties of 5'-UTRs are found in transcripts of many genes, which are regulated by translational control mechanisms, we asked whether ADAM10 expression is…

Five prime untranslated regionenzymology [Brain]ADAM10ADAM10 protein humanBACE1-ASgenetics [Amyloid Precursor Protein Secretases]genetics [Alzheimer Disease]genetics [ADAM Proteins]BiochemistryGene Expression Regulation Enzymologicbiosynthesis [Membrane Proteins]ADAM10 ProteinAlzheimer DiseaseChlorocebus aethiopsAmyloid precursor proteinProtein biosynthesisbiosynthesis [Amyloid beta-Peptides]genetics [Amyloid beta-Peptides]AnimalsHumansGene RegulationMolecular BiologySequence Deletionbiosynthesis [ADAM Proteins]Amyloid beta-PeptidesbiologyBase SequenceP3 peptideenzymology [Alzheimer Disease]BrainMembrane ProteinsCell BiologyMolecular biologyBiochemistry of Alzheimer's diseasegenetics [Membrane Proteins]ADAM Proteinsbiosynthesis [Amyloid Precursor Protein Secretases]Protein Biosynthesisddc:540COS Cellsbiology.proteinAmyloid Precursor Protein Secretases5' Untranslated RegionsAmyloid precursor protein secretase
researchProduct

Prevenció de la malaltia d'Alzheimer en etapes primerenques i mitjanes de la vida

2015

La malaltia d'Alzheimer és la causa més freqüent de demència a l'edat adulta. A més, la seua incidència s'incrementa fortament amb l'edat i, és per això, que la seua prevalença està augmentant en tot el món degut a l'augment a l'expectativa de vida. Clínicament es caracteritza per un dèficit cognitiu progressiu i irreversible i alteracions de la conducta que afecten a la memòria i altres dominis cognitius, a la capacitat d'aprenentatge, activitats de la vida diària i, en últim terme, a la qualitat de vida. Donat que el tractament farmacèutic disponible actualment solament pot millorar moderadament els símptomes, la modificació de factors de risc a etapes primerenques i mitjanes de la vida é…

General Earth and Planetary Sciences:PSICOLOGÍA [UNESCO]Demència Alzheimer prevenció envelliment dèficit cognitiu qualitat de vida factors de risc factors de protecció activitat física activitat cognitiva dieta estil de vida evidència actual. ArtículoUNESCO::PSICOLOGÍAGeneral Environmental Science
researchProduct

Role of prothrombotic polymorphisms in successful or unsuccessful aging.

2011

The study of the genetic profile of centenarians aims to identify the genes and allelic variants which may influence a greater life expectancy and that can be considered as predisposing factors associated to the aging diseases, such as Alzheimer. Centenarians, that represent a cohort of selected survivors, show an hypercoagulability state characterised by striking signs of high coagulation enzyme activity, as directly assessed by the tested higher plasma level of some important factors involved in the haemostasis balance. Anyway, these individuals seem to have a reduced susceptibility to dementia, as well as to cardiovascular events. In this study we analyze the frequencies of Leiden Factor…

GerontologyMaleAging.media_common.quotation_subjectDiseaseBioinformaticsLeiden factor V; Prothrombin; Nonagenarians; Alzheimer disease; Aging.Polymorphism (computer science)Alzheimer DiseasemedicineDementiaHumansNonagenarianAlleleAllelesmedia_commonAgedSettore MED/04 - Patologia GeneralePolymorphism GeneticSuccessful agingbusiness.industryALZHEIMER’S DISEASEagingLongevityFactor Vmedicine.diseaseCase-Control StudiesCohortFemaleProthrombinGeriatrics and GerontologyAlzheimer's diseasebusinessGerontologyLeiden Factor V
researchProduct

Predictors of Falls and Fractures Leading to Hospitalization in People With Dementia: A Representative Cohort Study.

2018

OBJECTIVES: Investigate predictors of falls and fractures leading to hospitalization in a large cohort of people with dementia. DESIGN: A retrospective cohort study. SETTING AND PARTICIPANTS: People with diagnosed dementia between January 2007 and March 2013, aged >65 years, were assembled using data from the Maudsley Biomedical Research Centre Case Register, from 4 boroughs in London serving a population of 1.3 million people. MEASURES: Falls and/or fractures leading to hospitalization were ascertained from linked national records. Demographic data, cognitive test scores, medications, and symptom and functioning scores from Health of the Nation Outcome Scales (HoNOS65+) were modeled in mul…

GerontologyMaleGeriatrics & Gerontology*dementiaHealth StatusPoison controlFalls fractures dementia hospital admission Alzheimer’s disease mortalityOccupational safety and healthCohort Studies*mortalityFractures Bone0302 clinical medicine*hospital admissionResidence CharacteristicsLondon030212 general & internal medicineRegistriesGeneral NursingASSOCIATIONSeducation.field_of_studyHealth PolicyAge FactorsPAINGeneral MedicinefracturesAlzheimer's diseaseHospitalizationSURVIVALFallsFemaleHEALTHLife Sciences & BiomedicineCohort studyPopulation03 medical and health sciencesSex FactorsInjury preventionmedicineDementiaHumansVascular dementiaeducationOLDER-ADULTS*FallsAgedRetrospective StudiesScience & Technologybusiness.industry*Alzheimer's diseaseMORTALITY*fracturesRetrospective cohort studymedicine.diseaseCOGNITIVE IMPAIRMENThospital admissionRISK-FACTORSAccidental FallsDementiaGeriatrics and Gerontologybusiness030217 neurology & neurosurgerydementiaJournal of the American Medical Directors Association
researchProduct